{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:41:19Z","timestamp":1792809679817,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"16","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2010,4,22]]},"DOI":"10.1038\/onc.2009.523","type":"journal-article","created":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T11:17:03Z","timestamp":1265023023000},"page":"2427-2440","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Cadherin switching and activation of p120 catenin signaling are mediators of gonadotropin-releasing hormone to promote tumor cell migration and invasion in ovarian cancer"],"prefix":"10.1038","volume":"29","author":[{"given":"L W T","family":"Cheung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P C K","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A S T","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,2,1]]},"reference":[{"key":"BFonc2009523_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1196\/annals.1294.006","volume":"1014","author":"U Cavallaro","year":"2004","unstructured":"Cavallaro U, Christofori G . (2004). Multitasking in tumor progression: signaling functions of cell adhesion molecules. Ann N Y Acad Sci 1014: 58\u201366.","journal-title":"Ann N Y Acad Sci"},{"key":"BFonc2009523_CR2","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s12020-007-0041-8","volume":"31","author":"CL Chen","year":"2007","unstructured":"Chen CL, Cheung LW, Lau MT, Choi JH, Auersperg N, Wang HS et al. (2007). Differential role of gonadotropin-releasing hormone on human ovarian epithelial cancer cell invasion. Endocrine 31: 311\u2013320.","journal-title":"Endocrine"},{"key":"BFonc2009523_CR3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/mrd.10121","volume":"62","author":"GT Chen","year":"2002","unstructured":"Chen GT, Tai CT, Yeh LS, Yang TC, Tsai HD . (2002). Identification of the cadherin subtypes present in the human peritoneum and endometriotic lesions: potential role for P-cadherin in the development of endometriosis. Mol Reprod Dev 62: 289\u2013294.","journal-title":"Mol Reprod Dev"},{"key":"BFonc2009523_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1210\/er.2003-0039","volume":"26","author":"CK Cheng","year":"2005","unstructured":"Cheng CK, Leung PC . (2005). Molecular biology of gonadotropin-releasing hormone (GnRH)-I, GnRH-II, and their receptors in humans. Endocr Rev 26: 283\u2013306.","journal-title":"Endocr Rev"},{"key":"BFonc2009523_CR5","doi-asserted-by":"publisher","first-page":"10902","DOI":"10.1158\/0008-5472.CAN-06-2217","volume":"66","author":"LW Cheung","year":"2006","unstructured":"Cheung LW, Leung PC, Wong AS . (2006). Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9. Cancer Res 66: 10902\u201310910.","journal-title":"Cancer Res"},{"key":"BFonc2009523_CR6","doi-asserted-by":"publisher","first-page":"5479","DOI":"10.1111\/j.1742-4658.2008.06677.x","volume":"275","author":"LW Cheung","year":"2008","unstructured":"Cheung LW, Wong AS . (2008). Gonadotropin-releasing hormone: GnRH receptor signaling in extrapituitary tissues. FEBS J 275: 5479\u20135495.","journal-title":"FEBS J"},{"key":"BFonc2009523_CR7","doi-asserted-by":"publisher","first-page":"5716","DOI":"10.1158\/0008-5472.CAN-08-0001","volume":"68","author":"JH Choi","year":"2008","unstructured":"Choi JH, Park JT, Davidson B, Morin PJ, Shih Ie M, Wang TL . (2008). Jagged-1 and Notch3 juxtacrine loop regulates ovarian tumor growth and adhesion. Cancer Res 68: 5716\u20135723.","journal-title":"Cancer Res"},{"key":"BFonc2009523_CR8","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.cell.2006.10.018","volume":"127","author":"H Clevers","year":"2006","unstructured":"Clevers H . (2006). Wnt\/beta-catenin signaling in development and disease. Cell 127: 469\u2013480.","journal-title":"Cell"},{"key":"BFonc2009523_CR9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0277-5379(89)90011-4","volume":"25","author":"G Emons","year":"1989","unstructured":"Emons G, Pahwa GS, Brack C, Sturm R, Oberheuser F, Knuppen R . (1989). Gonadotropin releasing hormone binding sites in human epithelial ovarian carcinomata. Eur J Cancer Clin Oncol 25: 215\u2013221.","journal-title":"Eur J Cancer Clin Oncol"},{"key":"BFonc2009523_CR10","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1006\/dbio.1996.0318","volume":"180","author":"F Fagotto","year":"1996","unstructured":"Fagotto F, Gumbiner BM . (1996). Cell contact-dependent signaling. Dev Biol 180: 445\u2013454.","journal-title":"Dev Biol"},{"key":"BFonc2009523_CR11","first-page":"6688","volume":"62","author":"CM Feltes","year":"2002","unstructured":"Feltes CM, Kudo A, Blaschuk O, Byers SW . (2002). An alternatively spliced cadherin-11 enhances human breast cancer cell invasion. Cancer Res 62: 6688\u20136697.","journal-title":"Cancer Res"},{"key":"BFonc2009523_CR12","first-page":"817","volume":"55","author":"G Irmer","year":"1995","unstructured":"Irmer G, Burger C, Muller R, Ortmann O, Peter U, Kakar SS et al. (1995). Expression of the messenger RNAs for luteinizing hormone-releasing hormone (LHRH) and its receptor in human ovarian epithelial carcinoma. Cancer Res 55: 817\u2013822.","journal-title":"Cancer Res"},{"key":"BFonc2009523_CR13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3322\/CA.2007.0010","volume":"58","author":"A Jemal","year":"2008","unstructured":"Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T et al. (2008). Cancer statistics, 2008. CA Cancer J Clin 58: 71\u201396.","journal-title":"CA Cancer J Clin"},{"key":"BFonc2009523_CR14","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1385\/ENDO:13:3:297","volume":"13","author":"SK Kang","year":"2000","unstructured":"Kang SK, Cheng KW, Nathwani PS, Choi KC, Leung PC . (2000). Autocrine role of gonadotropin-releasing hormone and its receptor in ovarian cancer cell growth. Endocrine 13: 297\u2013304.","journal-title":"Endocrine"},{"key":"BFonc2009523_CR15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1677\/erc.1.01033","volume":"13","author":"KY Kim","year":"2006","unstructured":"Kim KY, Choi KC, Auersperg N, Leung PC . (2006). Mechanism of gonadotropin-releasing hormone (GnRH)-I and -II-induced cell growth inhibition in ovarian cancer cells: role of the GnRH-I receptor and protein kinase C pathway. Endocr Relat Cancer 13: 211\u2013220.","journal-title":"Endocr Relat Cancer"},{"key":"BFonc2009523_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1210\/endo.135.1.8013383","volume":"135","author":"SL Li","year":"1994","unstructured":"Li SL, Vuagnat B, Gruaz NM, Eshkol A, Sizonenko PC, Aubert ML . (1994). Binding kinetics of the long-acting gonadotropin-releasing hormone (GnRH) antagonist antide to rat pituitary GnRH receptors. Endocrinology 135: 45\u201352.","journal-title":"Endocrinology"},{"key":"BFonc2009523_CR17","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.1038\/sj.onc.1209396","volume":"25","author":"M Maeda","year":"2006","unstructured":"Maeda M, Johnson E, Mandal SH, Lawson KR, Keim SA, Svoboda RA et al. (2006). Expression of inappropriate cadherins by epithelial tumor cells promotes endocytosis and degradation of E-cadherin via competition for p120(ctn). Oncogene 25: 4595\u20134604.","journal-title":"Oncogene"},{"key":"BFonc2009523_CR18","doi-asserted-by":"publisher","first-page":"22565","DOI":"10.1074\/jbc.M101907200","volume":"276","author":"KC Miranda","year":"2001","unstructured":"Miranda KC, Khromykh T, Christy P, Le TL, Gottardi CJ, Yap AS et al. (2001). A dileucine motif targets E-cadherin to the basolateral cell surface in Madin-Darby canine kidney and LLC-PK1 epithelial cells. J Biol Chem 276: 22565\u201322572.","journal-title":"J Biol Chem"},{"key":"BFonc2009523_CR19","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1083\/jcb.147.3.631","volume":"147","author":"MT Nieman","year":"1999","unstructured":"Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ . (1999). N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 147: 631\u2013644.","journal-title":"J Cell Biol"},{"key":"BFonc2009523_CR20","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1083\/jcb.144.6.1235","volume":"144","author":"CD Nobes","year":"1999","unstructured":"Nobes CD, Hall A . (1999). Rho GTPases control polarity, protrusion, and adhesion during cell movement. J Cell Biol 144: 1235\u20131244.","journal-title":"J Cell Biol"},{"key":"BFonc2009523_CR21","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1083\/jcb.150.3.567","volume":"150","author":"NK Noren","year":"2000","unstructured":"Noren NK, Liu BP, Burridge K, Kreft B . (2000). p120 catenin regulates the actin cytoskeleton via Rho family GTPases. J Cell Biol 150: 567\u2013580.","journal-title":"J Cell Biol"},{"key":"BFonc2009523_CR22","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1126\/science.7652575","volume":"269","author":"MF Olson","year":"1995","unstructured":"Olson MF, Ashworth A, Hall A . (1995). An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science 269: 1270\u20131272.","journal-title":"Science"},{"key":"BFonc2009523_CR23","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/bcr1774","volume":"9","author":"J Paredes","year":"2007","unstructured":"Paredes J, Correia AL, Ribeiro AS, Albergaria A, Milanezi F, Schmitt FC . (2007). P-cadherin expression in breast cancer: a review. Breast Cancer Res 9: 214.","journal-title":"Breast Cancer Res"},{"key":"BFonc2009523_CR24","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/ijc.11086","volume":"106","author":"IS Patel","year":"2003","unstructured":"Patel IS, Madan P, Getsios S, Bertrand MA, MacCalman CD . (2003). Cadherin switching in ovarian cancer progression. Int J Cancer 106: 172\u2013177.","journal-title":"Int J Cancer"},{"key":"BFonc2009523_CR25","doi-asserted-by":"publisher","first-page":"41227","DOI":"10.1074\/jbc.M006578200","volume":"275","author":"S Pece","year":"2000","unstructured":"Pece S, Gutkind JS . (2000). Signaling from E-cadherins to the MAPK pathway by the recruitment and activation of epidermal growth factor receptors upon cell-cell contact formation. J Biol Chem 275: 41227\u201341233.","journal-title":"J Biol Chem"},{"key":"BFonc2009523_CR26","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.devcel.2006.10.010","volume":"11","author":"M Perez-Moreno","year":"2006","unstructured":"Perez-Moreno M, Fuchs E . (2006). Catenins: keeping cells from getting their signals crossed. Dev Cell 11: 601\u2013612.","journal-title":"Dev Cell"},{"key":"BFonc2009523_CR27","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1038\/sj.emboj.7600136","volume":"23","author":"X Qian","year":"2004","unstructured":"Qian X, Karpova T, Sheppard AM, McNally J, Lowy DR . (2004). E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases. EMBO J 23: 1739\u20131748.","journal-title":"EMBO J"},{"key":"BFonc2009523_CR28","first-page":"3544","volume":"54","author":"CL Sommers","year":"1994","unstructured":"Sommers CL, Gelmann EP, Kemler R, Cowin P, Byers SW . (1994). Alterations in beta-catenin phosphorylation and plakoglobin expression in human breast cancer cells. Cancer Res 54: 3544\u20133552.","journal-title":"Cancer Res"},{"key":"BFonc2009523_CR29","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1158\/0008-5472.CAN-04-2020","volume":"65","author":"A Soubry","year":"2005","unstructured":"Soubry A, van Hengel J, Parthoens E, Colpaert C, Van Marck E, Waltregny D et al. (2005). Expression and nuclear location of the transcriptional repressor Kaiso is regulated by the tumor microenvironment. Cancer Res 65: 2224\u20132233.","journal-title":"Cancer Res"},{"key":"BFonc2009523_CR30","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1677\/ERC-06-0073","volume":"14","author":"D Spentzos","year":"2007","unstructured":"Spentzos D, Cannistra SA, Grall F, Levine DA, Pillay K, Libermann TA et al. (2007). IGF axis gene expression patterns are prognostic of survival in epithelial ovarian cancer. Endocr Relat Cancer 14: 781\u2013790.","journal-title":"Endocr Relat Cancer"},{"key":"BFonc2009523_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0303-7207(03)00068-6","volume":"202","author":"K Sundfeldt","year":"2003","unstructured":"Sundfeldt K . (2003). Cell-cell adhesion in the normal ovary and ovarian tumors of epithelial origin; an exception to the rule. Mol Cell Endocrinol 202: 89\u201396.","journal-title":"Mol Cell Endocrinol"},{"key":"BFonc2009523_CR32","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S1535-6108(02)00150-2","volume":"2","author":"K Suyama","year":"2002","unstructured":"Suyama K, Shapiro I, Guttman M, Hazan RB . (2002). A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor. Cancer Cell 2: 301\u2013314.","journal-title":"Cancer Cell"},{"key":"BFonc2009523_CR33","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1158\/0008.5472.CAN-04-3646","volume":"65","author":"K Taniuchi","year":"2005","unstructured":"Taniuchi K, Nakagawa H, Hosokawa M, Nakamura T, Eguchi H, Ohigashi H et al. (2005). Overexpressed P-cadherin\/CDH3 promotes motility of pancreatic cancer cells by interacting with p120ctn and activating rho-family GTPases. Cancer Res 65: 3092\u20133099.","journal-title":"Cancer Res"},{"key":"BFonc2009523_CR34","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1242\/jcs.000455","volume":"121","author":"MJ Wheelock","year":"2008","unstructured":"Wheelock MJ, Shintani Y, Maeda M, Fukumoto Y, Johnson KR . (2008). Cadherin switching. J Cell Sci 121: 727\u2013735.","journal-title":"J Cell Sci"},{"key":"BFonc2009523_CR35","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/(SICI)1097-0215(19990412)81:2<180::AID-IJC3>3.0.CO;2-7","volume":"81","author":"AS Wong","year":"1999","unstructured":"Wong AS, Maines-Bandiera SL, Rosen B, Wheelock MJ, Johnson KR, Leung PC et al. (1999). Constitutive and conditional cadherin expression in cultured human ovarian surface epithelium: influence of family history of ovarian cancer. Int J Cancer 81: 180\u2013188.","journal-title":"Int J Cancer"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2009523.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2009523","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2009523.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T17:28:02Z","timestamp":1647883682000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2009523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,1]]},"references-count":35,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2010,4,22]]}},"alternative-id":["BFonc2009523"],"URL":"https:\/\/doi.org\/10.1038\/onc.2009.523","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,1]]},"assertion":[{"value":"11 June 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}